1
|
Chen L, Zhong Z, Liu J, Wen C, Jin Y, Wang X. Metabolic Changes in Mouse Plasma after Acute Diquat Poisoning by UPLC-MS/MS. CURR PHARM ANAL 2021. [DOI: 10.2174/1573412916999200624160304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Introduction:
Diquat is a fast-acting contact herbicide and plant dehydrating agent. The oral lethal dose 50
(LD50) of diquat in mice is about 125 mg/kg. The purpose of this study is to research the metabolomics in mouse plasma
after acute diquat poisoning.
Method:
These mice were divided into two groups (the control group and acute diquat poisoning group). The control
group was given normal saline by gavage. The acute diquat poisoning group was given 50 mg/kg diquat. UPLC-MS/MS
was used to determinate the small molecule organic acid in mouse plasma.
Results:
Compare to the control group, the L-lysine, Adenine, L-Alanine, L-Valine, Lactic acid, Inosine, Adenosine, LTryptophan, L-Tyrosine, L-Arginine, L-Phenylalanine, L-Methionine, Citric acid, Fructose, L-Glutamine, Malic acid, LAspartic acid and Pyruvic acid increased in the acute diquat poisoning group (p<0.05); while the L-Histidine decreased
(p<0.05).
Conclusion:
The results of metabolites increased or decreased, indicating that acute diquat poisoning induced amino acid
metabolism and energy metabolism perturbations in mice.
Collapse
Affiliation(s)
- Lianguo Chen
- The Third Clinical Institute Affiliated with Wenzhou Medical University & Wenzhou People's Hospital, Wenzhou 325000,China
| | - Zuoquan Zhong
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035,China
| | - Jiawen Liu
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035,China
| | - Congcong Wen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035,China
| | - Yongxi Jin
- Department of Rehabilitation, Wenzhou Municipal Hospital of Traditional Chinese Medicine, Wenzhou 325005,China
| | - Xianqin Wang
- Analytical and Testing Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou,China
| |
Collapse
|
2
|
Wen C, Zhou C, Jin Y, Hu Y, Wang H, Wang X, Yang X. Metabolic Changes in Rat Plasma After Epilepsy by UPLC-MS/MS. CURR PHARM ANAL 2021. [DOI: 10.2174/1573412916666200206145207] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Introduction:
Epilepsy is one of the most common neurological diseases in clinical practice.
The combined application of metabolomics technology plays a great advantage in the screening of biomarkers.
Methods:
In this study, Wistar rats were used as experimental subjects to model intractable epilepsy
and to detect the metabolic changes of small molecules in plasma. UPLC-MS/MS was used to determine
the small molecules in rat plasma. UPLC HSS C18 (2.1mm×100mm, 1.7 μm) column was used
for separation, column temperature of 40°C. The initial mobile phase was acetonitrile -0.3% formic
acid with gradient elution, the flow rate was 0.3 mL/min, total running time 4.0 min. Quantitative analysis
was performed with multi-response monitoring (MRM).
Results:
Compared to the control group, the L-Alanine and L-Arginine decreased in the Epilepsy group
(p<0.05); while Cytosine, Adenosine, L-Tyrosine, Citric acid, Fructose increased (p<0.05).
Conclusion:
In the screening of epilepsy biomarkers using metabolomics, various amino acids that
lead to increased energy production and neurotransmitter imbalance play an important role in epileptic
seizures.
Collapse
Affiliation(s)
- Congcong Wen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035,China
| | - Caiping Zhou
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035,China
| | - Yongxi Jin
- Department of Rehabilitation, Wenzhou Municipal Hospital of Traditional Chinese Medicine, Wenzhou 325005,China
| | - Yujie Hu
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035,China
| | - Hongzhe Wang
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035,China
| | - Xianqin Wang
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035,China
| | - Xuezhi Yang
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000,China
| |
Collapse
|
3
|
Zhang Q, Li D, Ma B, Wang X, Yang J, Chen D, Ye L. Pharmacokinetics and tissue distribution study of hupehenenine in rats: A novel isosteroid alkaloid isolated from Bulbus Hupehensis Fritillariae. Biomed Chromatogr 2021; 35:e5122. [PMID: 33772812 DOI: 10.1002/bmc.5122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2020] [Revised: 03/15/2021] [Accepted: 03/22/2021] [Indexed: 02/05/2023]
Abstract
Hupehenenine is a novel isosteroid alkaloid that was first isolated from Bulbus Hupehensis Fritillariae. The inhibitory proliferation effect of hupehenenine and its three related alkaloid derivatives, including o-caproyl-hupehenenine, o-(2-furanoyl)-hupehenenine, and Δ5(6) -isopeimine on human lung cancer cell line, human chronic myeloid leukemia cell line, and human thyroid duct cancer cell line in vitro, has been identified. This study first developed a sensitive HPLC-MS/MS method for the simultaneous quantification of hupehenenine and three alkaloid derivatives in rat plasma and tissues. The developed method was validated, and it was linear over the concentration range of 1-800 ng/mL for all analytes with R2 ≥ 0.9939 and 0.9972, respectively, in rat plasma and rat liver homogenate. The lower limit of quantitation was 1 ng/mL for all analytes. The intra-day and inter-day precision and accuracy were satisfactory. This validated method was successfully applied to investigate the pharmacokinetics and tissue distribution of hupehenenine in rats. In pharmacokinetic study, the maximum plasma concentration of rats exists gender difference. Tissue distribution study showed that hupehenenine has good affinity for multiple tissues but is unable to cross the blood-brain barrier. These results may provide a useful reference for further research of hupehenenine and its three related alkaloid derivatives.
Collapse
Affiliation(s)
- Qinyan Zhang
- West China School of Pharmacy, Sichuan University, Chengdu, China
| | - Dongguo Li
- West China School of Pharmacy, Sichuan University, Chengdu, China
| | - Bihua Ma
- West China School of Pharmacy, Sichuan University, Chengdu, China
| | - Xueyan Wang
- West China Hospital, Sichuan University, Chengdu, China
| | - Junyi Yang
- West China School of Pharmacy, Sichuan University, Chengdu, China
| | - Donglin Chen
- West China School of Pharmacy, Sichuan University, Chengdu, China
| | - Liming Ye
- West China School of Pharmacy, Sichuan University, Chengdu, China
| |
Collapse
|
4
|
Chen S, Ma J, Wang X, Geng P. UPLC–MS/MS simultaneous determination of methamphetamine, amphetamine, morphine, monoacetylmorphine, ketamine, norketamine, MDMA, and MDA in hair. ACTA CHROMATOGR 2020. [DOI: 10.1556/1326.2019.00615] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Hair is a stable specimen and has a longer detection window (from weeks to months) than blood and urine. Through the analysis of hair, the long-term information of the drug use of the identified person could be explored. Our work is to establish an ultra-performance liquid chromatography–tandem mass spectroscopy (UPLC–MS/MS) method for simultaneous determination of methamphetamine, amphetamine, morphine, monoacetylmorphine, ketamine, norketamine, 3,4-methylenedioxymethamphetamine (MDMA), and 3,4-methylenedioxyamphetamine (MDA) in hair. Methoxyphenamine was used as an internal standard. The chromatographic separation was performed on a UPLC ethylene bridged hybrid (BEH) C18 (2.1 mm × 50 mm, 1.7 μm) column using a mobile phase of acetonitrile–water with 10 mmol/L ammonium acetate solution which containing 0.05% ammonium hydroxide. The multiple reaction monitoring in positive electrospray ionization was used for quantitative determination. The intra-day and inter-day precisions (relative standard deviation [RSD]) were below 15%. The accuracy ranged between 85.5% and 110.4%, the average recovery rate was above 72.9%, and the matrix effect ranged between 92.7% and 109.2%. Standard curves were in the range of 0.05–5.0 ng/mg, and the correlation coefficients were greater than 0.995. The established UPLC–MS/MS method was applied to analyze the hair samples successfully.
Collapse
Affiliation(s)
- Siyuan Chen
- 1 School of Pharmaceutical Sciences, Wenzhou Medical UniversityWenzhou 325035, China
- 2 Institute of Forensic Science, Wenzhou Medical UniversityWenzhou 325035, China
| | - Jianshe Ma
- 1 School of Pharmaceutical Sciences, Wenzhou Medical UniversityWenzhou 325035, China
| | - Xianqin Wang
- 1 School of Pharmaceutical Sciences, Wenzhou Medical UniversityWenzhou 325035, China
- 2 Institute of Forensic Science, Wenzhou Medical UniversityWenzhou 325035, China
| | - Peiwu Geng
- 3 Laboratory of Clinical Pharmacy, The People's Hospital of LishuiLishui 323000, China
| |
Collapse
|
5
|
Weng Q, Chen L, Ye L, Lu X, Yu Z, Wen C, Chen Y, Huang G. Determination of licochalcone A in rat plasma by UPLC–MS/MS and its pharmacokinetics. ACTA CHROMATOGR 2019. [DOI: 10.1556/1326.2018.00491] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- Qinghua Weng
- The Third Clinical Institute Affiliated to Wenzhou Medical University & Wenzhou People's Hospital, Wenzhou 325000, China
| | - Lianguo Chen
- The Third Clinical Institute Affiliated to Wenzhou Medical University & Wenzhou People's Hospital, Wenzhou 325000, China
| | - Luxin Ye
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, 325035, China
| | - Xiaojie Lu
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, 325035, China
| | - Zheng Yu
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, 325035, China
| | - Congcong Wen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, 325035, China
| | - Yichuan Chen
- The Third Clinical Institute Affiliated to Wenzhou Medical University & Wenzhou People's Hospital, Wenzhou 325000, China
| | - Gang Huang
- Department of Traditional Chinese Medicine, The Sixth Affiliated Hospital of Wenzhou Medical University, The People's Hospital of Lishui, Lishui 323000, China
- Institute of Integrated Traditional Chinese and Western Medicine of Lishui, Lishui 323000, China
| |
Collapse
|
6
|
Ultra-high performance liquid chromatography-MS/MS (UHPLC-MS/MS) in practice: analysis of drugs and pharmaceutical formulations. FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES 2019. [DOI: 10.1186/s43094-019-0007-8] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
Abstract
Background
UHPLC-MS/MS is connected in various research facilities for the qualitative and quantitative investigation of a pharmaceutical substance, pharmaceutical items, and biological specimen.
Main body
The commence review article is an endeavor to offer pervasive awareness around assorted aspects and details about the UHPLC-MS/MS and related techniques with the aim on practice to an estimation of medicinal active agents in the last 10 years. The article also focused on isolation, separation, and characterization of present impurity in drug and biological samples.
Conclusion
Review article compiles a general overview of medicinally important drugs and their analysis with UHPLC-MS/MS. It gives fundamental thought regarding applications of UHPLC-MS/MS for the study on safety limit. The summary of developed UHPLC-MS/MS methods gives a contribution to the future trend and limitations in this area of research.
Collapse
|
7
|
Ye W, Sun W, Chen R, Wang Z, Cui X, Zhang H, Qian S, Zheng Q, Zhou Y, Wan J, Xu J, Wang X, Zhou Y. Pharmacokinetics in rat plasma and tissue distribution in mice of galangin determined by UHPLC–MS/MS. ACTA CHROMATOGR 2019. [DOI: 10.1556/1326.2017.00389] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- Weijian Ye
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Wei Sun
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Ruijie Chen
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Zhe Wang
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Xiao Cui
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Hui Zhang
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Shuyi Qian
- Analytical and Testing Center, Wenzhou Medical University, Wenzhou 325035, China
| | - Qi Zheng
- Analytical and Testing Center, Wenzhou Medical University, Wenzhou 325035, China
| | - Yangfeng Zhou
- Analytical and Testing Center, Wenzhou Medical University, Wenzhou 325035, China
| | - Jiafeng Wan
- Analytical and Testing Center, Wenzhou Medical University, Wenzhou 325035, China
| | - Jiali Xu
- Analytical and Testing Center, Wenzhou Medical University, Wenzhou 325035, China
| | - Xianqin Wang
- Analytical and Testing Center, Wenzhou Medical University, Wenzhou 325035, China
| | - Yunfang Zhou
- Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, Lishui, 323000, China
| |
Collapse
|
8
|
Chen L, Wu H, Tu X, Zhao Y, Jiang Y, Wen C, Luo Y. Simultaneous determination of atractylenolide I and II in rat plasma by UPLC–MS/MS and its application to pharmacokinetic study after intravenous administration. ACTA CHROMATOGR 2019. [DOI: 10.1556/1326.2017.00274] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Lianguo Chen
- Department of Pharmacy, Wenzhou People's Hospital, Wenzhou, China
| | - Haiya Wu
- The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China
| | - Xiaoting Tu
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, China
| | - Yi Zhao
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, China
| | - Yanyan Jiang
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, China
| | - Congcong Wen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, China
| | - Yue Luo
- The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China
| |
Collapse
|
9
|
Geng P, Luo X, Peng X, Lin Z, Chen W, Zhang J, Wen C, Hu L, Hu S. Development and validation of UPLC–MS/MS method for determination of eupatilin in rat plasma and its application in a pharmacokinetics study. ACTA CHROMATOGR 2018. [DOI: 10.1556/1326.2017.00320] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Peiwu Geng
- The Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, Lishui 323000, China
| | - Xinhua Luo
- Department of Clinical Lab Medicine, Taizhou Municipal Hospital affiliated with Taizhou University, Taizhou 318000, China
| | - Xiufa Peng
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| | - Zixia Lin
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| | - Wenhao Chen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| | - Jin Zhang
- The Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, Lishui 323000, China
| | - Congcong Wen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| | - Lufeng Hu
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
| | - Siyi Hu
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
| |
Collapse
|
10
|
Determination of Puquitinib in Human Plasma by HPLC–ESI MS/MS: Application to Pharmacokinetic Study. Eur J Drug Metab Pharmacokinet 2018. [PMID: 29520719 PMCID: PMC6133078 DOI: 10.1007/s13318-018-0468-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Background and Objective Puquitinib mesylate (XC-302) is a new multiple-target anticancer inhibitor, which directly suppresses the activity of phosphatidylinositol 3-kinase (PI3K). This study was aimed to develop a sensitive and specific liquid chromatography electrospray ionization tandem mass spectrometry (HPLC–ESI MS/MS) method for the quantification and pharmacokinetic investigation of plasma puquitinib in cancer patients. Methods The analytes of human plasma were prepared by liquid–liquid extraction using methyl-t-butyl ether (MTBE). The plasma analytes were separated by HPLC on Thermo ODS Hypersil column (2.1 × 150 mm; 3 μm) at 25 °C with 5 mmol/L ammonium acetate (A)-acetonitrile (B) (30:70, v/v) as the mobile phase. Results The total run time was 3.5 min and the elution of puquitinib was at 1.38 min. The detection were analyzed by multiple reaction monitoring (MRM) mode with positive-ion electrospray ionization (ESI) interface using the respective [M + H]+ ions: m/z 318.2 → 261.1 for puquitinib and m/z 258.2 → 121.0 for the internal standard (etofesalamide). The optimized method provided a good linear relation over the concentration range of 1.00-500.00 ng/mL (r = 0.9944) for puquitinib. The intra-day and inter-day precision (relative standard deviation [RSD%]) were within 9.83%, and the intra-day and inter-day accuracy ranged from 91.05 to 103.26%. The lower limit of quantitation (LLOQ) was 1.00 ng/mL. The absolute extraction recovery was on an average of 50.43% for puquitinib and 49.3% for internal standard. In addition, the maximum plasma concentration (Cmax) of puquitinib in dosage from 50 to 800 mg/m2 in the human study showed an increased linearly (57.1–1289.2 ng/mL), which displayed that the concentrations had reached effective levels. Conclusions The optimized method was successfully applied to the pharmacokinetic profile study in human cancer patient plasma after the oral administration of puquitinib.
Collapse
|
11
|
Chen L, Weng Q, Li F, Liu J, Zhang X, Zhou Y. Pharmacokinetics and Bioavailability Study of Tubeimoside I in ICR Mice by UPLC-MS/MS. JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY 2018; 2018:9074893. [PMID: 30116651 PMCID: PMC6079592 DOI: 10.1155/2018/9074893] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/25/2018] [Accepted: 06/19/2018] [Indexed: 06/08/2023]
Abstract
The aim of this study is to establish and validate a rapid, selective, and sensitive ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method to determine tubeimoside I (TBMS-I) in ICR (Institute of Cancer Research) mouse whole blood and its application in the pharmacokinetics and bioavailability study. The blood samples were precipitated by acetonitrile to extract the analytes. Chromatographic separation was performed on a UPLC BEH C18 column (2.1 mm × 50 mm, 1.7 μm). The mobile phase consisted of water with 0.1% formic acid and methanol (1 : 1, v/v) at a flow rate of 0.4 mL/min. The total eluting time was 4 min. The TBMS-I and ardisiacrispin A (internal standard (IS)) were quantitatively detected by a tandem mass spectrometry equipped with an electrospray ionization (ESI) in a positive mode by multiple reaction monitoring (MRM). A validation of this method was in accordance with the US Food and Drug Administration (FDA) guidelines. The lower limit of quantification (LLOQ) of TBMS-I was 2 ng/mL, and the calibration curve was linearly ranged from 2 to 2000 ng/mL (r2 ≥ 0.995). The relative standard deviation (RSD) of interday precision and intraday precision was both lower than 15%, and the accuracy was between 91.7% and 108.0%. The average recovery was >66.9%, and the matrix effects were from 104.8% to 111.0%. In this assay, a fast, highly sensitive, and reproducible quantitative method was developed and validated in mouse blood for the first time. The absolute availability of TBMS-I in the mouse was only 1%, exhibiting a poor oral absorption.
Collapse
Affiliation(s)
- Lianguo Chen
- Wenzhou People's Hospital, The Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou 325000, China
| | - Qinghua Weng
- Wenzhou People's Hospital, The Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou 325000, China
| | - Feifei Li
- Wenzhou People's Hospital, The Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou 325000, China
| | - Jinlai Liu
- Wenzhou People's Hospital, The Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou 325000, China
| | - Xueliang Zhang
- Wenzhou People's Hospital, The Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou 325000, China
| | - Yunfang Zhou
- Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China
| |
Collapse
|
12
|
Zhou Y, Chen B, Chen J, Dong Y, Wang S, Wen C, Wang X, Yu X. Determination and pharmacokinetic study of jaceosidin in rat plasma by UPLC–MS/MS. ACTA CHROMATOGR 2018. [DOI: 10.1556/1326.2017.00104] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- Yunfang Zhou
- The Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, Lishui 323000, China
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| | - Bingbao Chen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| | - Junyan Chen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| | - Yanwen Dong
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| | - Shuanghu Wang
- The Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, Lishui 323000, China
| | - Congcong Wen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| | - Xianqin Wang
- Analytical and Testing Center, Wenzhou Medical University, Wenzhou 325035, China
| | - Xiaomin Yu
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China
| |
Collapse
|
13
|
Geng P, Zhang J, Chen B, Wang Q, Wang S, Wen C. Determination and pharmacokinetic study of dauricine in rat plasma by UPLC–MS/MS. ACTA CHROMATOGR 2018. [DOI: 10.1556/1326.2017.00118] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- Peiwu Geng
- The Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, Wenzhou Medical University, Lishui 323000, China
| | - Jing Zhang
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| | - Bingbao Chen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| | - Qianqian Wang
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| | - Shuanghu Wang
- The Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, Wenzhou Medical University, Lishui 323000, China
| | - Congcong Wen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou 325035, China
| |
Collapse
|
14
|
Scheeren LE, Nogueira-Librelotto DR, Fernandes JR, Macedo LB, Marcolino AIP, Vinardell MP, Rolim CMB. Comparative Study of Reversed-Phase High-Performance Liquid Chromatography and Ultraviolet–Visible Spectrophotometry to Determine Doxorubicin in pH-Sensitive Nanoparticles. ANAL LETT 2018. [DOI: 10.1080/00032719.2017.1380034] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- Laís E. Scheeren
- Departamento de Farmácia Industrial, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil
| | - Daniele R. Nogueira-Librelotto
- Departamento de Farmácia Industrial, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil
| | - Joana R. Fernandes
- Departamento de Farmácia Industrial, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil
| | - Letícia B. Macedo
- Departamento de Farmácia Industrial, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil
| | - Ana Isa P. Marcolino
- Departamento de Farmácia Industrial, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil
| | - M. Pilar Vinardell
- Departament de Bioquimica I Fisiologia, Facultat de Farmàcia I Ciències de l’Alimentació, Universitat de Barcelona, Barcelona, Spain
| | - Clarice M. B. Rolim
- Departamento de Farmácia Industrial, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Santa Maria, Santa Maria, Rio Grande do Sul, Brazil
| |
Collapse
|
15
|
|
16
|
Fang B, Bao S, Wang S, Chen M, Chen B, Su K, Wen C, Zhou Y, Wang X, Jin Y. Pharmacokinetic study of ardisiacrispin A in rat plasma after intravenous administration by UPLC-MS/MS. Biomed Chromatogr 2016; 31. [PMID: 27565758 DOI: 10.1002/bmc.3826] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2016] [Revised: 08/11/2016] [Accepted: 08/22/2016] [Indexed: 11/10/2022]
Abstract
In this work, a sensitive and selective UPLC-MS/MS method for determination of ardisiacrispin A in rat plasma was developed. Cyasterone used as an internal standard (IS) and protein precipitation by acetonitrile-methanol (9:1, v/v) was used to prepare samples. Chromatographic separation was achieved on a UPLC BEH C18 column (2.1 × 100 mm, 1.7 μm) with 0.1% formic acid and acetonitrile as the mobile phase with gradient elution. An electrospray ionization source was applied and operated in positive ion mode; multiple reaction monitoring mode was used for quantification using target fragment ions m/z 1083.5 → 407.1 for ardisiacrispin A and m/z 521.3 → 485.2 for IS. Calibration plots were linear throughout the range 5-2000 ng/mL for ardisiacrispin A in rat plasma. Mean recoveries of ardisiacrispin A in rat plasma ranged from 80.4 to 92.6%. The values of RSD of intra- and inter-day precision were both <11%. The accuracy of the method was between 97.3 and 105.6%. The method was successfully applied to pharmacokinetic study of ardisiacrispin A after intravenous administration in rats.
Collapse
Affiliation(s)
- Bingmu Fang
- Department of Hematology, The People's Hospital of Lishui, Lishui, 323000, China
| | - Shihui Bao
- The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, 325000, China
| | - Shuanghu Wang
- Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, Lishui, 323000, China
| | - Minle Chen
- Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, Lishui, 323000, China
| | - Bingbao Chen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, 325035, China
| | - Ke Su
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, 325035, China
| | - Congcong Wen
- Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, 325035, China
| | - Yunfang Zhou
- Laboratory of Clinical Pharmacy, The People's Hospital of Lishui, Lishui, 323000, China
| | - Xianqin Wang
- Analytical and Testing Center, Wenzhou Medical University, Wenzhou, 325035, China
| | - Yuepeng Jin
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China
| |
Collapse
|